Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome
- PMID: 28367163
- PMCID: PMC5368334
- DOI: 10.12669/pjms.331.11764
Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome
Abstract
Objective: To evaluate the therapeutic effects of metformin and clomiphene in combination with lifestyle adjustment on infertility in women with obese polycystic ovarian syndrome (PCOS).
Methods: A total of 101 infertile women with obese PCOS admitted to our hospital from July 2013 to July 2015 were randomly divided into an observation group (n=51) and a control group (n=50). The control group was treated with metformin plus clomiphene, based on which the observation group was also subjected to lifestyle adjustment. The body weight, body mass index (BMI) and waist-to-hip ratio (WHR) were measured before and after treatment. The changes of reproductive hormones, ovaries and endometrium were detected, and the rates of menstrual recovery, ovulation and pregnancy were observed.
Results: The body weight and BMI of the observation group after treatment were significantly lower than those before treatment and of the control group (P<0.05). There was no significant difference in WHR between the two groups. In the observation group, there were significant differences in LH, T, LH/FSH, FINS and TG levels before and after treatment and from those of the control group after treatment (P<0.05). Both the left and right ovarian volumes of the observation group after treatment were significantly lower than those before treatment and of the control group after treatment (P<0.05). The menstrual recovery, ovulation and pregnancy rates of the observation group were significantly higher than those of the control group (P<0.05).
Conclusion: Lifestyle adjustment combined with metformin and clomiphene can improve the reproductive endocrine and lipid metabolism of obese PCOS patients, decrease the volumes of left and right ovaries, and increase the menstrual recovery, ovulation and pregnancy rates.
Keywords: Clomiphene; Infertility; Lifestyle Intervention; Metformin; Obesity; Polycystic ovary syndrome.
Similar articles
-
[Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].Zhonghua Fu Chan Ke Za Zhi. 2004 Sep;39(9):586-90. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15498183 Clinical Trial. Chinese.
-
Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.Fertil Steril. 2002 Jan;77(1):101-6. doi: 10.1016/s0015-0282(01)02941-7. Fertil Steril. 2002. PMID: 11779598 Clinical Trial.
-
Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome.J Obstet Gynaecol. 2003 May;23(3):289-93. doi: 10.1080/01443610310000100123. J Obstet Gynaecol. 2003. PMID: 12850864 Clinical Trial.
-
Reproductive impact of polycystic ovary syndrome.Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):505-11. doi: 10.1097/MED.0b013e328359ff92. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 23108198 Review.
-
Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome.Fertil Steril. 2003 Mar;79(3):469-81. doi: 10.1016/s0015-0282(02)04800-8. Fertil Steril. 2003. PMID: 12620424 Review.
Cited by
-
Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms.Pharmaceuticals (Basel). 2021 Jan 8;14(1):42. doi: 10.3390/ph14010042. Pharmaceuticals (Basel). 2021. PMID: 33429918 Free PMC article. Review.
-
A randomized sham-controlled trial of manual acupuncture for infertile women with polycystic ovary syndrome.Integr Med Res. 2022 Jun;11(2):100830. doi: 10.1016/j.imr.2021.100830. Epub 2021 Dec 28. Integr Med Res. 2022. PMID: 35059289 Free PMC article. Review.
-
Pharmacological and non-pharmacological strategies for obese women with subfertility.Cochrane Database Syst Rev. 2021 Mar 25;3(3):CD012650. doi: 10.1002/14651858.CD012650.pub2. Cochrane Database Syst Rev. 2021. PMID: 33765343 Free PMC article.
-
Acupuncture for hormonal readiness and gut microbiota in obese polycystic ovary syndrome: an open-label, randomized controlled trial.Front Endocrinol (Lausanne). 2024 Dec 19;15:1509152. doi: 10.3389/fendo.2024.1509152. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39749020 Free PMC article. Clinical Trial.
-
Lifestyle Interventions for Adults with Infertility.J Lifestyle Med. 2022 May 31;12(2):69-71. doi: 10.15280/jlm.2022.12.2.69. J Lifestyle Med. 2022. PMID: 36157889 Free PMC article. Review.
References
-
- Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 2003;79(3):562–566. - PubMed
-
- De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. Drugs Today (Barc) 2009;45(10):763–775. doi:1396674/dot.2009.45.10.1429463. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. - PubMed
-
- Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2007;356(6):551–566. - PubMed
-
- Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, et al. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol. 2007;157(5):669–676. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous